Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003
Erradication of intraperitoneal and distant tumour by adenovirus-mediated interferon-beta gene therapy due to induction of systemic immunity Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001
MIP-3alpha gene therapy combined with localized radiation therapy boost anti-tumor immunity in a murine model of lung carcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth in vivo by retrovirus-mediated gene transfer Source: Annual Congress 2002 - Thoracic oncology: biology Year: 2002
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004
Intratumoral injection of plasmid-encoded flagellin inhibits growth of NSCLC-cells in murine lung cancer model Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
Novel anti-angiogenic pharmacotherapy strategies Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Combination gene therapy with conditionally replicating adenovirus and adenovirus-p27 of lung cancer Source: Annual Congress 2004 - Management of lung cancer and innovative therapies Year: 2004
Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005
Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008
The neoadjuvant therapy of NSCLC down-regulates serum levels of growth factors (VEGF, bFGF, TGF-beta) with no effect on apoptosis (CD95L) and local tumour invasiveness markers (TIMP-1) Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006
Targeted therapy in nonsmall cell lung cancer Source: Eur Respir Mon; 2009: 44: 284–298 Year: 2009
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy Source: Eur Respir J, 53 (3) 1801562; 10.1183/13993003.01562-2018 Year: 2019